Skip to content

ICAAC: Moxifloxacin as effective as ethambutol in TB treatment

Limb fat gains lower when switching from AZT to abacavir or tenofovir, compared with d4T

HAART reduces liver damage in HIV / hepatitis C co-infected patients

Premature to say atazanavir not linked to fat loss, says lipodystrophy expert

Neurological side-effects of efavirenz mild and transient, study claims

Less than half of deaths at London HIV clinic due to AIDS since 1998

Previous immune damage and response to HIV treatment associated with TB after starting antiretrovirals

Hospitalisations and deaths down in US, slight increase in number of admissions due to liver problems

TB treatment and diagnostics pipeline: once empty, suddenly offers new hope for TB care